Equities

Dolby Laboratories Inc

Dolby Laboratories Inc

Actions
  • Price (EUR)69.50
  • Today's Change0.50 / 0.72%
  • Shares traded--
  • 1 Year change-13.83%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 18:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Sep 29 2023202320222021
ASSETS
Cash And Short Term Investments8858091,264
Total Receivables, Net444420415
Total Inventory362411
Prepaid expenses242730
Other current assets, total993140
Total current assets1,4881,3111,760
Property, plant & equipment, net522560602
Goodwill, net408365341
Intangibles, net167112123
Long term investments9810363
Note receivable - long term------
Other long term assets955561
Total assets2,9802,6903,106
LIABILITIES
Accounts payable211418
Accrued expenses215180205
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total1878393
Total current liabilities422278316
Total long term debt000
Total debt000
Deferred income tax------
Minority interest174.846.25
Other liabilities, total185161186
Total liabilities625443508
SHAREHOLDERS EQUITY
Common stock0.090.090.10
Additional paid-in capital------
Retained earnings (accumulated deficit)2,3922,2982,608
Treasury stock - common------
Unrealized gain (loss)(2.86)(5.99)0.22
Other equity, total(34)(46)(10)
Total equity2,3552,2462,598
Total liabilities & shareholders' equity2,9802,6903,106
Total common shares outstanding9696101
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.